Medicine and Dentistry
Acute Kidney Injury
10%
Acute Respiratory Distress Syndrome
18%
Adverse Event
6%
Anticoagulation
11%
Artificial Respiration
20%
Burnout
9%
Cardiovascular System
10%
Central Venous Pressure
7%
Chronic Kidney Disease
8%
Clinical Trial
16%
COVID-19
100%
COVID-19 Vaccination
8%
COVID-19 Vaccine
27%
Diabetes
7%
Disease
16%
Disease Severity
10%
Dyspnea
8%
Echocardiography
9%
Emergency Department
12%
Fluid Resuscitation
10%
Heart Arrest
7%
Heparin
9%
Hypertensive Factor
29%
Hypotension
8%
Infection
7%
Influenza Vaccination
8%
Influenza Vaccine
26%
Intensive Care
6%
Intensive Care Unit
22%
Intubation
38%
Laryngoscopy
11%
Noninvasive Ventilation
7%
Observational Study
19%
Obstructive Sleep Apnea
9%
Odds Ratio
17%
Placebo
42%
Pulmonary Hypertension
17%
Randomized Clinical Trial
25%
Respiratory Disease
10%
Respiratory Tract Infection
8%
Resuscitation
17%
RNA Vaccine
9%
Sepsis
25%
Severe Acute Respiratory Syndrome Coronavirus 2
15%
Shock (Circulatory)
15%
Symptom
7%
Thromboprophylaxis
10%
Tracheal Intubation
24%
Treprostinil
9%
Vaccine Hesitancy
9%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lung Injury
6%
Adult Respiratory Distress Syndrome
21%
All Cause Mortality
9%
Baricitinib
9%
Biological Marker
7%
Cardiovascular Disease
9%
Cholecalciferol
9%
Chronic Kidney Failure
6%
Clinical Trial
20%
Cohort Study
8%
Comorbidity
8%
Controlled Clinical Trial
11%
Coronavirinae
45%
COVID-19 Vaccine
34%
Critical Illness
7%
Disease
56%
Disease Exacerbation
7%
Disease Severity
8%
Diseases
6%
Heart Arrest
8%
Heart Ventricle Arrhythmia
9%
Heparin
9%
Hydroxychloroquine
9%
Hypertensive Factor
27%
Hypotension
11%
Hypoxemia
10%
Infection
23%
Inflammation
6%
Influenza Vaccine
25%
Infusion Fluid
6%
Intubation
24%
Monoclonal Antibody
6%
mRNA Vaccine
40%
Observational Study
11%
Pandemic
9%
Placebo
68%
Prevalence
7%
Pulmonary Hypertension
19%
Randomized Clinical Trial
27%
Remdesivir
7%
Renin
9%
Respiratory Failure
7%
Respiratory Tract Disease
11%
RNA Vaccine
9%
SARS Coronavirus
35%
Sepsis
10%
Sleep Disordered Breathing
9%
Symptom
7%
Treprostinil
9%
Vaccination Policy
31%
Keyphrases
Adjusted Odds Ratio
6%
Anticoagulation
12%
Bolus Administration
8%
Cardiovascular Collapse
9%
Clinical Outcomes
7%
Confidence Interval
22%
COVID-19
47%
COVID-19 Vaccine
10%
COVID-19-associated Hospitalization
14%
Critically Ill
10%
Critically Ill Adults
16%
Critically Ill Patients
36%
Emergency Intubation
10%
Endotracheal Intubation
19%
Fluid Bolus
10%
Heparin
9%
High Dose
9%
Hispanic
6%
Hospitalization
13%
Hospitalized Adults
9%
Hypotension
7%
Hypoxemia
8%
Illness
6%
Influenza
6%
Influenza Vaccine Effectiveness
9%
Intensive Care Unit
10%
Intubation
19%
MRNA Vaccine
11%
Multicenter Observational Study
9%
Obstructive Sleep Apnea
9%
Older Men
9%
Oral Treprostinil
9%
Placebo
14%
Placebo Groups
7%
Primary Series
6%
Randomized Clinical Trial
20%
Resuscitation
7%
Septic Shock
8%
Shock
10%
Test-negative Design
10%
Therapeutic Agents
9%
Therapeutic Anticoagulation
9%
Thromboprophylaxis
12%
United States
25%
Usual Care
10%
Vaccination
9%
Vaccine against COVID-19
10%
Vaccine Effectiveness
29%
Vasopressors
17%
Vitamin D3
9%
